Homogenates of rat small intestine can depolymerize macromolecular rat skin heparin (RS heparin) to products similar in size to commercial heparin [Homer (1972) Proc. Natl. Acad. Sci. U.S.A. 69,[3469][3470][3471][3472][3473]. This activity is attributed to an enzyme provisionally named 'macromolecular heparin depolymerase'. An assay for macromolecular heparin depolymerase activity in rat small intestine has been developed, based on the action of the enzyme on 35S-labelled macromolecular RS heparin. The depolymerized products are separated into two peaks by gel chromatography through columns of Bio-Gel A-1 5m. The amount of label in the second peak, expressed as a percentage of the total radioactivity, is the index of enzyme activity. The pH optimum was found to be 6.0 and the temperature optimum 45°C. The enzyme was shown to be most stable in 50mM-Tris/ maleate buffer containing 1 mM-EDTA. Macromolecular heparin depolymerase activity measured as a function of time and substrate concentration produced curves typical of an enzymic reaction. Evidence was obtained demonstrating that the activity did not originate from bacteria in the intestine. Macromolecular heparin depolymerase activity was increased by dilution and storage at 7°C for 24h. This suggests that homogenates of rat small intestine contain an unstable inhibitor of the enzyme.
maleate buffer containing 1 mM-EDTA. Macromolecular heparin depolymerase activity measured as a function of time and substrate concentration produced curves typical of an enzymic reaction. Evidence was obtained demonstrating that the activity did not originate from bacteria in the intestine. Macromolecular heparin depolymerase activity was increased by dilution and storage at 7°C for 24h. This suggests that homogenates of rat small intestine contain an unstable inhibitor of the enzyme.
Rat skin heparin (RS heparin) has been shown to be a macromolecular complex composed of heparin chains linked covalently to a core structure (Horner, 1970b (Horner, , 1971 . This core region appears to be a polypeptide composed of alternating serine and glycine residues with the polysaccharide chains attached to serine units via O-glycosidic linkages to xylose residues (Robinson et al., 1978; Horner & Young, 1979) . The molecular weight of RS heparin was calculated to be approx. 1.1 x106 (Horner, 1971) , which is more than an order of magnitude greater than that of commercial preparations (Johnson & Mulloy, 1976) . High-molecular-weight heparins have also been found in mouse mastocytoma (Ogren & Lindahl, 1971) , rat peritoneal mast cells (Horner, 1977; Yurt et al., 1977) and monkey tissues (Horner, 1976) .
A preparation from rat small intestine was shown to depolymerize macromolecular RS heparin to products whose molecular size was similar to that of commercial pig mucosal heparin (Horner, 1972) .
Abbreviations used: RS heparin, rat skin heparin; PM heparin, pig mucosal heparin. Vol. 180 This depolymerizing activity has been provisionally named 'macromolecular heparin depolymerase'.
In addition to its anticoagulant effect, heparin is known for its antilipaemic action. Heparin stimulates the release of lipoprotein lipase (clearing-factor lipase), an enzyme that hydrolyses the triacylglycerols (triglycerides) of circulating chylomicrons and low-density lipoproteins (Robinson, 1963) . When tested for its effect on lipoprotein lipase, RS heparin was found to exhibit poor lipoprotein lipase-releasing activity in vivo and actually inhibited this enzyme in vitro. However, lower-molecular-weight products formed by the action of macromolecular heparin depolymerase displayed lipoprotein lipase-releasing activity both in vivo and in vitro (Homer, 1972) . Since macromolecular RS heparin may be a precursor form that must be depolymerized in vivo before it can exert its physiological effect, a study of macromolecular heparin depolymerase would contribute knowledge to the metabolism and possible physiological role of heparin. In the present paper we describe an assay for measuring macromolecular heparin depolymerase activity in homogenates of rat small intestine. By use of this assay, various properties of the depolymerase activity were studied. Lam et al. (1976) , with pig mucosal heparin as standard.
Radioactivity was counted with a NuclearChicago mark I liquid-scintillation system. PCS solubilizer (lOml/glass vial) was employed as the scintillation medium.
Gel electrophoresis was conducted in 1 % agarose films as described by Horner (1975) .
Gel chromatography was performed at room temperature on columns of Bio-Gel A-15m (200-400 mesh) (0.9cmx27cm). Samples to be chromatographed were dissolved in 1.OM-NaCl (0.5ml) and applied to the columns, which were equilibrated and eluted with the same solvent. A flow rate of 4ml/h was maintained. Fractions were collected by dropcounting with an LKB Ultrorac type 7000 fraction collector.
DEAE-cellulose anion-exchange chromatography was carried out at 7°C on columns (1.5 cm x 20cm) of DEAE-Sephacel (Cl-form) equilibrated with 0.3M-NaCl adjusted to pH2.5 with HCI. The samples to be fractionated were dissolved in this solution, applied to the columns, and then eluted with a linear gradient formed by adding 190ml of 2.0M-NaCl, pH2.5, to 190ml of 0.3M-NaCl, pH2.5. Fractions (5ml) were collected by drop-counting.
Preparation ofsubstrate
Batches of 35S-labelled RS heparin were prepared from groups of six to eight male Wistar rats (body weight 200-300g) . Each rat was injected intraperitoneally with 2.OmCi of sodium [35S]sulphate in 0.15M-NaCl (1.0ml). The animals were killed with ether 18 h later and their skins were quickly removed and frozen. The labelled macromolecular RS heparin was prepared as previously described for unlabelled RS heparin (Horner, 1971) , with minor modifications. Bio-Gel A-50m was used for gel filtration instead of Sagavac 4F. A portion (50-100,u1) of each fraction eluted from Bio-Gel A-50m was taken for scintillation counting of radioactivity. The elution pattern showed two peaks, the first and larger of which was macromolecular RS heparin (Horner, 1971 200-350g) were killed with ether. Their small intestines, from the stomach to the caecum, were quickly removed and placed in ice-cold 50mM-Tris/maleate, pH7.4, containing 0.15 M-NaCl and 1 mM-EDTA. The intestines were slit lengthwise with the blunt end of dissection scissors, rinsed extensively with the above buffer to remove contents and cut into small pieces. The wet weight of the tissue was determined after straining on a fine steel wire mesh. The wet weight averaged 8g per rat. Fresh buffer (50mM-Tris/maleate/1 mM-EDTA, pH7.4) was added in a wet weight/buffer ratio of 3 g to 4ml.
The To recover labelled RS heparin, each precipitate was stirred magnetically at room temperature for 12h with 6ml of 2.4M-NaCl containing dextran sulphate 2000 (0.33 mg/ml). After centrifuging at 12000g for 30min at room temperature the supernatant was removed and a second extraction of the insoluble material was carried out as above. Finally a third extraction was made with 5 ml of 2.4M-NaCI. The three supernatants were combined and the NaCl concentration was adjusted to 1.2M by adding distilled water.
The next stage involved the use of cetylpyridinium chloride by using the principles described by Scott (1960) . A 14ml volume of cetylpyridinium chloride solution (1 %, w/v, in 1.2M-NaCl) was added slowly to the combined supernatants, with constant magnetic stirring, in tubes that were warmed to 35°C in a water bath to facilitate complex-formation.
This mixture was transferred to a 25 ml plastic centrifugal filter assembly (Filterfuge; Millipore Corporation) fitted with a 1.2,um (type RA) Millipore filter and containing Hyflo Super-Cel (0.25g). Most of the clear filtrate passed through the filter by gravity. Final traces were removed by centrifuging at 200g for 10min at room temperature. The filter pad was washed with two 2ml portions of warm 0.1 % cetylpyridinium chloride in 1.2M-NaCl. The heparin-cetylpyridinium chloride complex was then dissociated with four 2ml portions of warm (40°C) 2.4M-NaCl. The washings and extractions were carried out in the same way as the initial filtration. The combined extracts were adjusted to 1.OM-NaCl with distilled water, and heparin was precipitated by Vol. 180 adding 3 vol. of ethanol. The carrier dextran sulphate was not displaced from its cetylpyridinium chloride complex by 2.4M-NaCl and was therefore retained on the -filter pad. After standing at 4°C overnight, the heparin precipitate was spun down at 900g for 90min and the supernatant discarded. The precipitation of heparin from 1.0M-NaCl by ethanol was repeated and the product was dried under reduced pressure at room temperature. The percentage recovery of radioactivity was expressed relative to a 100,ug sample of undegraded substrate.
Each recovered depolymerization product was dissolved in 1.0M-NaCl (0.5 ml), and the 35S-labelled heparins were fractionated by gel filtration on BioGel A-15m columns. A sample (100-500,ul) was taken from each 0.59ml fraction, mixed with PCS solubilizer in a glass vial and its radioactivity counted for 20min. Elution curves drawn from the radioactivity data showed two peaks, the second containing heparin chains released from the partially degraded macromolecular heparin present in the first peak. The percentage of total radioactivity in the second peak was taken as the index of macromolecular heparin depolymerase activity. The methods described above were used in most experiments and are referred to as standard conditions.
Results
Comments on the assay method for macromolecular heparin depolymerase activity Incubations were carried out under standard conditions for periods ranging from 1 to 10h and the products were fractionated on Bio-Gel A-15m columns. As a control, a sample of substrate was incubated with buffer only for 24h. Several typical elution profiles are shown in Fig. 1 . In most cases two peaks were obtained, but these always overlapped. This is an inevitable consequence of the polydisperse nature of the products. Therefore, in cases where enzymic depolymerization was either low or high (see 2 and 6h incubations; Fig. 1) , there existed the difficulty of determining where the division between peaks should be made. The dividing point for assignment of fractions to the two peaks was standardized by reference to an example where the separation into two peaks was distinct (see 4h incubation; Fig. 1 ). The assignment of fractions to the second peak was based on this criterion for every depolymerized product. The percentage of total radioactivity present in the second peak was used as the index of depolymerase activity. This is defined as percentage depolymerization (Table 1) (Bitter & Muir, 1962 Depolymerase activity was determined in homogenates of small intestine prepared with the standardized homogenization technique except that nine different buffers were used. These are listed in Table 2 . All buffers (except the three Tris buffers) were prepared as described by Dawson et al. (1969) . Each buffer also contained 1mM-EDTA. The pH values chosen for comparison were close to 7.0 and/or 6.0, as the effective range of the buffer permitted. Before homogenization, intestines were washed in the appropriate buffer system, containing 0.15 M-NaCI, at pH7.4. As this was not feasible with the sodium acetate buffer system, the intestines were washed with 50mM-Tris/HCI, pH7.4, containing 0.15M-NaCl. Homogenates were then prepared in the NaCl-free buffers listed in Homogenates were prepared in the various buffers by using the standardized homogenization conditions (see the Experimental section). All buffers (except those containing Tris) were prepared as described by Dawson et al. (1969 
Incubation with intestinal contents
Since the intestine contains an abundant bacterial flora (Dubos et al., 1965) , the possibility existed that the depolymerase activity was of bacterial origin. To check this possibility, the intestinal contents from a group of rats were removed and strained on cheese- first week, but at the end of 30 days the increase was similar to that observed for the 7°C samples. These experiments also showed that the enzyme can withstand freezing and thawing.
Influence of dilution and cold storage on macromolecular heparin depolymerase activity Portions of a standard enzyme preparation were (i) assayed immediately, (ii) kept at 7°C for 24 h and then assayed, or (iii) diluted with an equal volume of 50mM-Tris/maleate/1 mM-EDTA, pH 6.0, kept at 7°C for 24h and then assayed. In all three cases 5 ml samples were incubated for various times from 1 to 10h. The results of these incubations are shown in Fig. 7 . Clearly, the samples that were diluted 1 : 1 with buffer and kept at 7°C for 24h demonstrated the best activity. The effects of storage at 7'C and dilution on depolymerase activity appear to be additive.
Specific radioactivity of 35S-labelled RS heparin and its depolymerized products
The specific radioactivities of macromolecular 35S-labelled RS heparin and its depolymerized products were determined to discount the possibility of the action of a sulphate-transferring enzyme rather than a depolymerase.
Assay mixtures were incubated under standard conditions for 1, 2 and 3 h. For each time interval five 5 ml portions of homogenate were used. Each depolymerized product was recovered by standardized procedures with minor modifications. various storage times, these samples were assayed for depolymerase activity in the same way as the control. Before incubation, the frozen samples were permitted to thaw for 1 h at 7°C. The results ofthese experiments are summarized in Fig. 6 . Unexpectedly, the samples stored cold or frozen displayed increases in activity. The increase for the samples kept at 7°C was almost 30 %, and the enzyme was stable at this temperature for up to 1 week. The frozen samples did not display such a prominent increase (approx. 20 %) during the Vol. 180 Influence of dilution and storage at 7°C on macromolecular heparin depolymerase activity A standard enzyme preparation was assayed as described in the Experimental section for depolymerase activity. Samples were incubated immediately (A), stored at 7°C for 24h and then assayed (a), or diluted 1:1 with 50mM-Tris/maleate/ImM-EDTA, pH 6.0, stored at 7°C for 24h and then assayed (o). 627 + 9 * The standard deviation of each specific-radioactivity value was derived from the standard deviations of the corresponding radioactivity and heparin concentrations by the treatment of fractional (percentage) errors described by Wilson (1952) . When compared with macromolecular 35S-labelled RS heparin and with each other, there are no significant differences between any of the specific radioactivities by Student's t test (P> 0.05).
2.4M-NaCl washes containing dextran sulphate were pooled for each incubation period before the addition of 70ml of 1 % cetylpyridinium chloride in 1.2M-NaCl. After passage through the filter assembly, the heparin-cetylpyridinium chloride complex was dissociated with seven 2ml portions of warm 2.4M-NaCl, and the heparin was precipitated from I.OMNaCl with 3 vol. of ethanol.
The depolymerized products were digested with chondroitinase ABC to remove traces of chondroitin sulphates and/or dermatan sulphate detected by gel electrophoresis in 1 % agarose films. Each product was dissolved in 10ml of chondroitinase ABC buffer (Saito et al., 1968 ) containing 1.7 units of enzyme and incubated at 37°C. After 24h, each incubation mixture was adjusted to 1.OM-NaCI with solid salt and 2mg of dextran sulphate was added. Then I % cetylpyridinium chloride (6ml) was added, and heparin was recovered as described above.
After precipitation with ethanol each depolymerized product was further purified by DEAEcellulose anion-exchange chromatography (see the Experimental section). A 50,1 sample was taken from each 5ml fraction for counting of radioactivity. Those fractions comprising a peak of radioactive material were combined and precipitated from 1.0M-NaCl with 3 vol. of ethanol. A I00ug sample of IIS-labelled RS heparin was likewise precipitated. The heparin precipitates were spun down, washed with 75 % (v/v) ethanol followed by ethanol and then dried. After these purification procedures, approx. 70-80% of the original radioactivity was recovered for each depolymerized product. The purity of each product was confirmed by gel electrophoresis in 1 % agarose films. The products of incubation for 1, 2 and 3 h were depolymerized 29, 47 and 68 % respectively.
Each depolymerized product and the macromolecular 35S-labelled RS heparin was dissolved in water to a concentration appropriate for the determination of heparin concentration by the metachromatic Azure A method. Heparin concentrations and radioactivity were determined in 50,ul samples.
The results are shown in Table 4 . The close agreement between the specific radioactivities of macromolecular 35S-labelled RS heparin and of the depolymerized products from 1, 2 and 3 h of incubation indicates that homogenates of rat small intestine contain macromolecular heparin depolymerase activity rather than sulphate-transferring activity.
Discussion
The present work has demonstrated some of the properties of a macromolecular heparin depolymerase from rat small intestine and described an assay method for this enzyme. The substrate was a macromolecular heparin from rat skin (Horner, 1971) . Heparins of a similar macromolecular nature have also been identified in human and monkey tissue (Horner, 1970a (Horner, , 1976 , in rat peritoneal mast cells (Horner, 1977; Yurt et al., 1977) and in mouse mastocytoma tissue (Ogren & Lindahl, 1971 . The molecular weight of this mastocytomal macromolecular heparin is 69000: smaller than RS heparin but substantially larger than PM heparin (Ogren & Lindahl, 1971 ). An enzyme has been isolated from the particulate fraction of the same tissue with the ability to degrade this substrate into chains similar in size to commercial heparin (Ogren & Lindahl, 1975) . This enzyme has been named 'heparin-liberating enzyme' (Ogren & Lindahl, 1976) . It has also been shown to degrade RS heparin (Lindahl et al., 1977) , but the products have not been characterized. This enzyme differs from macromolecular heparin depolymerase in several respects. Its pH optimum is 5.0 (versus 6.0 for the intestinal depolymerase), and it is most active in an acetate 1979 buffer (Ogren & Lindahl, 1975) . Acetate inhibits macromolecular heparin depolymerase (see Table 2 ). The mastocytomal heparinase can be purified by precipitation with (NH4)2SO4 (Ogren & Lindahl, 1975) , which inactivated the intestinal depolymerase (E. Young, unpublished work). The mastocytomal enzyme has been tentatively identified as an endoglucuronidase on the basis of the reduction of the polysaccharide degradation products with NaB3H4 (Ogren & Lindahl, 1975 (Arbogast et al., 1977) and of rat spleen and in homogenates of human platelets (Hedlin et al., 1977) .
Instead of a depolymerase, it could be argued that the activity observed involved a sulphate-transferring enzyme. This type of enzyme might transfer the radioactive sulphate from the macromolecular RS heparin to endogenous low-molecular-weight heparins in rat small intestine. However, experiments to demonstrate heparin in rat intestine have revealed only trace amounts of a low-molecular-weight heparin-like molecule (E. Young, unpublished work). Also, the results from the present study have shown that the specific radioactivities of 35S-labelled RS heparin and its enzymically depolymerized products are almost identical. These observations support the concept of a depolymerase rather than of a sulphatetransferring enzyme.
In the assay procedure the use of dextran sulphate is obligatory to obtain good heparin recoveries. This indicates that in the intestinal homogenate supernatant heparin is strongly bound in some type of complex. It requires a more highly sulphated compound to displace heparin from this complex. A polypeptide similar to that isolated from peritoneal mast-cell granules (Bergqvist et al., 1971 ) and platelets (Da Prada et al., 1976) may be responsible for the heparin binding, but this has not been studied.
In earlier work with rat small intestine (Horner, 1972) depolymerase activity was solubilized by high-speed homogenization, followed by ultrasonication. In the present work we have used the Polytron homogenizer, which was designed to combine the effects of mechanical shearing and ultrasonic disruption of tissues. Our experience is that the efficiency of release of depolymerase activity is critically dependent on the condition of the Polytron generator. Comparison of the data in Tables 1 and 4 demonstrates this dramatically. The data in Table 1 were obtained with a PT 20-ST generator that had been in use for about 2 years: the values for depolymerization after 1, 2 and 3 h of incubation were 8, 14 and 35 % respectively. The data in Table 4 were obtained with a new PT 20-ST generator: the values for depolymerization after 1, 2 and 3 h of incubation were 29, 47 and 68% respectively. We suspect that the ultrasonication effect is decreased in older Polytron generators.
The activity of the depolymerase as assayed in our experiments was increased when diluted to 50 % or when kept at 7°C for 24h. These observations suggest that an inhibitor that became less effective on dilution or denatured on standing in the cold was involved.
The isolation of 35S-labelled macromolecular RS heparin has always been accompanied by a minor fraction of lower-molecular-weight heparin with the same specific radioactivity as that of the major macromolecular fraction (A. A. Horner, unpublished work) . In monkey tissues, heparins ranging from high to low molecular weights have been found (Horner, 1976) . Macromolecular heparin depolymerizing activity has also been reported in human intestine and spleen (Ogren & Lindahl, 1975) and in rat serum (Young et al., 1978) . These observations support the hypothesis that lower-molecular-weight chains are released from a macromolecular precursor by heparin depolymerases. Since macromolecular RS heparin is an inhibitor of lipoprotein lipase activity whereas depolymerized chains are activators (Horner, 1972) , these depolymerases may act physiologically by controlling the availability of low-molecularweight heparin chains to activate lipoprotein lipase. This work was supported by the Ontario Heart Foundation.
